Motilal Oswal upgrades Cipla's rating to 'Buy', while Dr Reddy's, Zydus Lifesciences, Lupin, Aurobindo Pharma, and Torrent Pharma maintain their ratings. Sun Pharma retains 'Buy' rating.
3 min read20 Sep 2023DSP Healthcare Fund generated the highest returns of 69.80% in the last one yearNifty pharma index grew by 51.5% in last one year
1 min read16 Aug 2020All in all, it seems like pharma stocks may continue to undershoot the broader market for quite some timeThe Indian pharmaceutical market, which has been hedging against lack of growth in the US, clocked slower growth last month
2 min read28 Feb 2020What could stand in good stead is control on costs and curtailing capacityThis would shore up returns on equity
2 min read20 Dec 2019The recent run-up in its stock price has raised the 12-month trailing earnings to around 39 times earnings per shareSome of its specialty brands helped Pfizer command better pricing, particularly in vaccines, vitamins and cardiovascular segments
1 min read9 Dec 2019A mature brand can be revived to generate handsome returns with little marketing expenses
4 min read7 Aug 2019The government had exempted innovative medicines made by foreign firms from price caps for five years
2 min read5 Jan 2019NGOs, however, have criticised the decision saying it shrinks the space to make medicines more affordable
1 min read4 Jan 2019The committee found that most pharma firms had not generated the 'safety and efficacy data' of their own FDCs
3 min read27 Jul 2018The policy focus must shift from the mere reduction of price to ensuring quality and safe medicines
4 min read16 Jul 2018The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared